China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise

Posted: 21 Mar 2012

See all articles by Vicki Sato

Vicki Sato

Harvard University

Christoph Jaeker

Harvard University - Business School (HBS)

Pooja Solanki

Harvard University - Business School (HBS)

Date Written: February 9, 2012

Abstract

As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the site. How sustainable was this strategy, and what were the key things he had to do right to establish a globally integrated R&D unit in China?

Learning Objective: Examine the issues surrounding the establishment of a new R&D facility in China that will be part of a global network.

Suggested Citation

Sato, Vicki and Jaeker, Christoph and Solanki, Pooja, China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise (February 9, 2012). Harvard Business School Technology & Operations Mgt. Unit Case No. 612-048, Available at SSRN: https://ssrn.com/abstract=2026575

Vicki Sato (Contact Author)

Harvard University ( email )

1875 Cambridge Street
Cambridge, MA 02138
United States

Christoph Jaeker

Harvard University - Business School (HBS) ( email )

Soldiers Field Road
Morgan 270C
Boston, MA 02163
United States

Pooja Solanki

Harvard University - Business School (HBS) ( email )

Soldiers Field Road
Morgan 270C
Boston, MA 02163
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
706
PlumX Metrics